Cargando…

Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination

BACKGROUND: Vaccines have substantially mitigated the disproportional impact of SARS-CoV-2 on the high morbidity and mortality experienced by nursing home residents. However, variation in vaccine efficacy, immune senescence and waning immunity all undermine vaccine effectiveness over time. The intro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gravenstein, Stefan, DeVone, Frank, Oyebanji, Oladayo A., Abul, Yasin, Cao, Yi, Chan, Philip A., Halladay, Christopher W., McConeghy, Kevin W., Nugent, Clare, Bosch, Jürgen, King, Christopher L., Wilson, Brigid M., Balazs, Alejandro B., White, Elizabeth M., Canaday, David H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168517/ https://www.ncbi.nlm.nih.gov/pubmed/37163130 http://dx.doi.org/10.1101/2023.04.25.23289050

Ejemplares similares

2373. "Longitudinal Investigation of Avidity Maturation following Multiple Doses of BNT162b2 mRNA Vaccine Including Bivalent Boosters among Nursing Home Residents and Healthcare Workers"
por: Oyebanji, Oladayo A, et al.
Publicado: (2023)

SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022
por: Canaday, David H., et al.
Publicado: (2023)

The effect of age on fever response among nursing home residents with SARS-COV-2 infection
por: Sachar, Moniyka, et al.
Publicado: (2022)

Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster
por: McConeghy, Kevin W., et al.
Publicado: (2022)

2396. In Nursing Home Residents, SARS-CoV-2 Boosters Reduced Sex Disparity in Vaccine Response Observed in Primary Series
por: Wilson, Brigid, et al.
Publicado: (2023)

Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2
por: Rudolph, James L., et al.
Publicado: (2020)

Can we clinically identify pre-symptomatic and asymptomatic COVID-19?
por: Elhamamsy, Salaheldin, et al.
Publicado: (2021)

Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers
por: Freeman, Michael L, et al.
Publicado: (2023)

Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
por: Nugent, Clare, et al.
Publicado: (2023)

901. The Impact of Cost-Free On-Site Influenza Point of Care Antigen Testing on Influenza Detection in Nursing Homes
por: Abdul, Yasin, et al.
Publicado: (2023)

Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents
por: Canaday, David H., et al.
Publicado: (2021)

COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents
por: Canaday, David H., et al.
Publicado: (2022)

Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents — 19 States, March 29–July 25, 2022
por: McConeghy, Kevin W., et al.
Publicado: (2022)

Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents
por: Canaday, David H, et al.
Publicado: (2021)

Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination
por: Canaday, David H, et al.
Publicado: (2021)

Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?
por: Oyebanji, Oladayo A., et al.
Publicado: (2021)

Risk factors for pneumonia and influenza hospitalizations in long-term care facility residents: a retrospective cohort study
por: Moyo, Patience, et al.
Publicado: (2020)

Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination
por: Canaday, David H., et al.
Publicado: (2021)

Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review
por: Bosco, Elliott, et al.
Publicado: (2021)

Vaccines for the Prevention of Coronavirus Disease 2019 in Older Adults
por: Oyebanji, Oladayo A., et al.
Publicado: (2023)

Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents
por: Bosco, Elliott, et al.
Publicado: (2021)

2730. Estimating Deaths Attributable to Influenza Mortality Using Traditional and Novel Forecasting Methods
por: McConeghy, Kevin, et al.
Publicado: (2019)

LB-19. Association between contract staffing and reported outbreaks of SARS-CoV-2 in a cluster-randomized trial of 965 U.S. nursing homes
por: McConeghy, Kevin, et al.
Publicado: (2020)

Preventing Urban Firearm Homicides during COVID-19: Preliminary Results from Three Cities with the Advance Peace Program
por: Corburn, Jason, et al.
Publicado: (2022)

Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

1953. Comparative Effectiveness of High- vs. Standard-Dose Influenza Vaccine on Hospitalization for Acute Myocardial Infarction in Nursing-Home Residents: A Post-hoc Analysis From a Large Cluster-Randomized Trial
por: Saade, Elie, et al.
Publicado: (2018)

Durability of Bivalent Boosters against Omicron Subvariants
por: Lin, Dan-Yu, et al.
Publicado: (2023)

Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2
por: Lally, Michelle A., et al.
Publicado: (2021)

Long-term Care Facility Variation in the Incidence of Pneumonia and Influenza
por: Bosco, Elliott, et al.
Publicado: (2019)

LONG-TERM CARE FACILITY VARIATION IN THE INCIDENCE OF PNEUMONIA AND INFLUENZA HOSPITALIZATIONS
por: Bosco, Elliott, et al.
Publicado: (2019)

Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

996. A Cluster-Randomized Trial of Adjuvanted Trivalent Influenza Vaccine vs. Standard Dose in US Nursing Homes
por: Gravenstein, Stefan, et al.
Publicado: (2018)

The burden of respiratory infections among older adults in long-term care: a systematic review
por: Childs, Arielle, et al.
Publicado: (2019)

Epidemiology and Clinical Presentation of COVID-19 in Older Adults
por: Abul, Yasin, et al.
Publicado: (2023)

Geographic Variation in Pneumonia and Influenza in Long-Term Care Facilities: A National Study
por: Bosco, Elliott, et al.
Publicado: (2020)

FACILITY CHARACTERISTICS, STAFF INJURY, AND DISRUPTIVE BEHAVIOR REPORTING RATES IN VA COMMUNITY LIVING CENTERS
por: Mohr, David, et al.
Publicado: (2019)

Freddie: annotation-independent detection and discovery of transcriptomic alternative splicing isoforms using long-read sequencing
por: Orabi, Baraa, et al.
Publicado: (2022)

Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium
por: Callaway, Heather M., et al.
Publicado: (2023)

EVALUATING THE IMPACT OF STAR-VA ON VETERANS’ PSYCHOTROPIC MEDICATION USE IN CLCS
por: McConeghy, Kevin, et al.
Publicado: (2019)

2170. The National Burden of Pneumonia and Influenza in U.S. Nursing Homes, 2013–2015
por: Mcconeghy, Kevin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0l4q0dk8v19onmq8b0sum7etdf